DelSiTech

Pre-clinical

Turku, FinlandFounded 2005delsitech.com

DelSiTech at-a-Glance DelSiTech is a technology platform company specializing in long-acting formulations, dedicated to transforming the treatment landscape in the areas of metabolic disease and pain through our lead long-acting injectable assets. DelSiTech’s proprietary Silica Matrix technology platform is highly versatile and has demonstrated compatibility with a wide range of therapeutic agents, including small molecules, peptides, and

Founded

2005

Focus

Drug Delivery

About

DelSiTech at-a-Glance DelSiTech is a technology platform company specializing in long-acting formulations, dedicated to transforming the treatment landscape in the areas of metabolic disease and pain through our lead long-acting injectable assets. DelSiTech’s proprietary Silica Matrix technology platform is highly versatile and has demonstrated compatibility with a wide range of therapeutic agents, including small molecules, peptides, and

Funding History

2

Total raised: $12M

Grant$2MBusiness FinlandMar 15, 2021

Series B$10MFinnish Industry InvestmentJun 15, 2019

Company Info

TypePrivate

Founded2005

LocationTurku, Finland

StagePre-clinical

Contact

Sectors

Drug Delivery & Formulation

SIMILAR COMPANIES

Pre-clinical · Turku

Faron Pharmaceuticals

Phase 1/2 · Turku

Finvector Vision Therapies

Pre-clinical · Kuopio

Pre-clinical · Kuopio

Genomill Health

Pre-clinical · Helsinki

Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.